Anti-histamine receptor 4 therapy inhibits choroidal neovascularization in mice

被引：0
|
作者：
Kaneko, Hiroki [1 ]
Ijima, Ryo [1 ]
Kachi, Shu [1 ]
Terasaki, Hiroko [1 ]
机构：
[1] Nagoya Univ, Ophthalmol, Nagoya, Aichi, Japan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2013年 / 54卷 / 15期
关键词：
412 age-related macular degeneration; 453 choroid: neovascularization; 688; retina;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
338
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Histamine Receptor H4 as a New Therapeutic Target for Choroidal Neovascularization in Age-related Macular Degeneration
    Ye, Fuxiang
    Kaneko, Hiroki
    Ijima, Ryo
    Kachi, Shu
    Kato, Seiichi
    Nagaya, Masatoshi
    Higuchi, Akiko
    Terasaki, Hiroko
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [22] Management of Myopic Choroidal Neovascularization: Focus on Anti-VEGF Therapy
    Teo, Kelvin Yi Chong
    Ng, Wei Yan
    Lee, Shu Yen
    Cheung, Chui Ming Gemmy
    DRUGS, 2016, 76 (11) : 1119 - 1133
  • [23] Management of Myopic Choroidal Neovascularization: Focus on Anti-VEGF Therapy
    Kelvin Yi Chong Teo
    Wei Yan Ng
    Shu Yen Lee
    Chui Ming Gemmy Cheung
    Drugs, 2016, 76 : 1119 - 1133
  • [24] Oral Anti-Cytokine Therapy for AMD: Fidarestat Suppresses Laser-Induced Choroidal Neovascularization in Mice
    Sugitani, K.
    Nozaki, M.
    Nakajima, A.
    Morimoto, N.
    Kato, N.
    Ogura, Y.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [25] The Anti-angiogenic Effects of Gold Nanoparticles on Experimental Choroidal Neovascularization in Mice
    Kang, S.
    Rho, C. R.
    Cho, W. K.
    Roh, Y. J.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [26] Inhibition of choroidal neovascularization by anti-EphB4 monoclonal antibody
    Su, Dongfeng
    Li, Xiaoqiu
    Gao, Dianwen
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (04) : 1226 - 1230
  • [27] Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Rupture-Associated Choroidal Neovascularization
    Russell, Jonathan F.
    Albini, Thomas A.
    Berrocal, Audina M.
    Dubovy, Sander R.
    Rosenfeld, Philip J.
    Smiddy, William E.
    Sridhar, Jayanth
    Townsend, Justin H.
    Flynn, Harry W., Jr.
    OPHTHALMOLOGY RETINA, 2020, 4 (02): : 226 - 228
  • [28] The Application of OCTA in Assessment of Anti-VEGF Therapy for Idiopathic Choroidal Neovascularization
    Chen, Qin
    Yu, Xiaobing
    Sun, Zihan
    Dai, Hong
    JOURNAL OF OPHTHALMOLOGY, 2016, 2016
  • [29] Secretogranin III as a novel target for anti-angiogenic therapy of choroidal neovascularization
    Li, Wei
    LeBlanc, Michelle
    Wang, Weiwen
    Ji, Yanli
    Liu, Dachuan
    Zhang, Xuxiang
    Tian, Hong
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [30] Safety review of anti-VEGF therapy in patients with myopic choroidal neovascularization
    Ng, Danny S. C.
    Ho, Mary
    Iu, Lawrence P. L.
    Lai, Timothy Y. Y.
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (01) : 43 - 54
12345